These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15799008)

  • 1. Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'.
    Loftis JM; Hauser P
    Hum Psychopharmacol; 2005 Apr; 20(3):211-2; author reply 213. PubMed ID: 15799008
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study.
    Kainuma M; Hikiami H; Nozaki K; Hayashi K; Shimada Y; Terasawa K
    Hum Psychopharmacol; 2004 Jun; 19(4):235-41. PubMed ID: 15181651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?
    Hosseini-Moghaddam SM; Mousavi A; Alavian SM
    J Antimicrob Chemother; 2009 Jun; 63(6):1097-103. PubMed ID: 19329508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.
    Mundt AP; Sarkar R; Winter C; Schaefer M; Ströhle A
    Psychosomatics; 2007; 48(1):86-7. PubMed ID: 17209157
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.
    Pariante CM; Landau S; Carpiniello B;
    N Engl J Med; 2002 Jul; 347(2):148-9. PubMed ID: 12110753
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case history of a patient with psychiatric disorders and multiple pharmacologically-managed comorbidities].
    Shao YL; Zhang SC; Zhou GF; Zou HZ; Shi LM; Ma CM; Wu JM; Guo FC; Tan FR
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):879-80. PubMed ID: 24516930
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.
    Fukuyama S; Kajiwara E; Suzuki N; Miyazaki N; Sadoshima S; Onoyama K
    Am J Gastroenterol; 2000 Jan; 95(1):310-2. PubMed ID: 10638610
    [No Abstract]   [Full Text] [Related]  

  • 10. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata induced by interferon alpha?
    Kernland KH; Hunziker T
    Dermatology; 1999; 198(4):418-9. PubMed ID: 10490302
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-induced hepatic failure in a patient with hepatitis C.
    Lock G; Reng CM; Graeb C; Anthuber M; Wiedmann KH
    Am J Gastroenterol; 1999 Sep; 94(9):2570-1. PubMed ID: 10484034
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing the neuropsychiatric complications of hepatitis C treatment.
    Sockalingam S; Shammi C; Stergiopoulos V
    Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Murderous impulses in two patients with chronic hepatitis C treated with interferon alpha].
    Rifflet H; Pol S; Vuillemin E; Oberti F; Duverger P; Lainé P; Garre JB; Calès P
    Gastroenterol Clin Biol; 1998 Jan; 22(1):105-6. PubMed ID: 9762179
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-induced haemolytic anaemia in hepatitis C.
    Al-Ansari M; Weilert F; Dickson G
    N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of sleep disturbance in hepatitis C.
    Sockalingam S; Abbey SE; Alosaimi F; Novak M
    J Clin Gastroenterol; 2010 Jan; 44(1):38-45. PubMed ID: 19730115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chronic HCV positive hemodialysis patient with an unusual treatment complication.
    Mousa D; Altayeb A
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):282-6. PubMed ID: 17612040
    [No Abstract]   [Full Text] [Related]  

  • 20. A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.
    Fisher ME; Rossini M; Simmons E; Harris RC; Moeckel G; Zent R
    Am J Kidney Dis; 2004 Sep; 44(3):567-73. PubMed ID: 15332232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.